Articles tagged with Covid 19 Vaccines
Receiving two doses of BNT162b2 vaccine was associated with lower risk of COVID-19 emergency department and outpatient visits. The risk appeared lower for those with two versus three doses, despite Omicron sublineages becoming dominant.
Researchers at George Washington University found that Facebook's core design features undermine its policies aimed at removing Covid-19 vaccine misinformation. The platform's architecture, designed to build communities around shared interests, can inadvertently facilitate the spread of misinformation.
A recent study published in the International Journal of Infectious Diseases found that individuals infected with the Omicron variant have a significantly lower risk of developing long COVID compared to those infected with earlier variants. The study analyzed data from over 11,000 people and found that around half of all wild-type infe...
A study of 50,000 COVID-19 cases found that immunity following infection provides better protection against transmission than vaccination, but only for a short period. Vaccination reduces contagiousness over a longer time, making it essential to consider simple public health measures like air filtration and mask-wearing.
The Mount Sinai Hospital received a $13 million NIH grant to create vaccines that can protect against various types of coronaviruses. The project aims to develop variant-proof, universal vaccines that offer broad protection against existing and future SARS-CoV-2 variants, pandemic, zoonotic, and seasonal coronaviruses.
A multi-state study confirmed that COVID-19 mRNA vaccination protects babies and young children against COVID-19-associated emergency department/urgent care visits. The study found that even one dose of the two-dose vaccine series provided some protection for this age group.
A new editorial paper explores the effectiveness of the third dose booster vaccine against SARS-CoV-2 in immunocompromised individuals. Researchers found that while the vaccine improves vaccine effectiveness across various measures, its benefits are not as significant for patients with cancer.
A study of health care workers found that co-administering COVID-19 and influenza vaccines was not associated with reduced immune response or increased adverse events. The results support the co-administration of these vaccines, suggesting a safer and more efficient vaccination strategy.
The new approach boosts immunity by engineering nanoparticles and antigens to stimulate a stronger immune response. The vaccine induces a strong immune response when delivered intranasally, potentially leading to longer-lasting immunity and reduced costs.
In a cohort study of 2,055 patients with glomerular diseases, COVID-19 vaccination did not worsen kidney damage or affect proteinuria. The data support vaccination for COVID-19 in patients with glomerular disease.
A recent study found that ChatGPT scored 9/10 in accuracy for debunking Covid-19 vaccine myths, making it a reliable source of non-technical information. The AI tool's responses were accurate in addressing both true and false contraindications, but highlighted potential concerns over changes in answers over time.
A new study found that nearly half of dog owners in the US hold negative views about vaccinating their pets, citing safety and efficacy concerns. This hesitancy is linked to public mistrust in human vaccines during the pandemic, posing serious public health implications for both animals and humans.
Two studies published by Aarhus University found that common side effects like malaise, fever, and fatigue occur frequently after COVID-19 vaccination. Menstruating women reported a 30% increase in menstrual cycle changes, with stress, age, and smoking contributing to the correlation.
A DNA-based vaccine has shown promise in a preclinical study by Scancell Ltd and Texas Biomedical Research Institute. The vaccine prompted a robust immune response, including T cell activation and antibody production.
Researchers have identified a key protein in SARS-CoV-2 that, when targeted, elicits a robust immune response. A live-attenuated vaccine based on this protein shows promise in preventing disease and offering long-lasting immunity. The approach could target areas of the genome less likely to change with variants.
Researchers are developing a community-based digital health intervention to increase vaccination uptake among children in rural and underserved areas. The project aims to empower community health workers to deliver education on vaccinations, overcoming the digital divide and addressing challenges faced by limited health workforce.
The CDI published a study tracking nasal swabs of thousands of patients in New Jersey, providing new insights into the pandemic's peak. The results highlight the importance of vaccination, reinforcing the positive impact of COVID-19 vaccination and public health benefits of genotypic surveillance.
A new essay highlights how news stories about healthcare workers during COVID-19 often left out crucial socioeconomic and environmental contexts, which can impact consumer thoughts and responses. By introducing a public health framework, experts aim to broaden storytelling and reframed scientific information dissemination.
Research identifies immunosuppressed individuals with lower antibody prevalence after three or more COVID-19 vaccine doses, highlighting increased vulnerability to severe infection. The MELODY study found that around one in five people with compromised immune systems had no COVID-19 antibodies.
Mayo Clinic researchers found that vaccinated patients with long-haul COVID were less likely to experience symptoms such as abdominal pain, chest pain, and shortness of breath. The study involved 477 patients who sought treatment for long-haul COVID at Mayo Clinic between May 27, 2021 and July 26, 2022.
Researchers tracked infections among Connecticut correctional facility residents to find that high exposure to the virus reduces vaccination and prior infection effectiveness. Hybrid immunity provides higher protection in such settings.
A Murdoch Children's Research Institute-led review found COVID-19 vaccines are effective against severe cases of the disease in children and adolescents. However, with most children now having caught the SARS-CoV-2 virus and building up a natural immunity, the additional benefit of vaccination in healthy children is minimal. The review...
A long-term study of nearly 2,400 solid organ transplant recipients found that COVID-19 vaccination significantly reduced hospitalization rates, with a 75% decrease in later omicron waves. Despite this, post-vaccination SARS-CoV-2 viral infections remain common, highlighting the importance of vaccination in high-risk populations.
Researchers developed a new method to assess immune responses to specific antigens after mRNA SARS-CoV-2 vaccine administration, using B cell receptor repertoire analysis. This approach enables evaluation of post-vaccination responses in immunocompromised patients with high antibody titers.
A new study found that around one in five people with compromised immune systems have no COVID-19 antibodies after three or more vaccinations. The MELODY study identified specific groups at higher risk of not producing antibodies, highlighting the need for targeted interventions and booster vaccines.
Researchers found that sequential vaccinations given in the same arm generated a stronger immune response than those administered in different arms. This is particularly true for cytotoxic CD8+ T cells and antibodies targeting the SARS-CoV-2 virus.
Scientists have discovered that SARS-CoV-2 can infect cells using multiple entry points beyond ACE2, explaining its ability to jump between species. This finding highlights the need for continued monitoring of coronaviruses and their potential to cause future pandemics.
Researchers found that COVID-19 vaccination generates antibodies in pregnant people that cross the placenta and protect their newborns against severe COVID-19 disease. Booster doses also increase maternal and newborn immune defenses against COVID-19, supporting the use of vaccination during pregnancy.
A third COVID-19 vaccination dose significantly improved antibody responses in transplant recipients, offering better protection against variants. However, cross-protection was only partial, highlighting the need for multiple vaccine doses to maintain immunity in this vulnerable population.
Pregnant individuals who received a full course of COVID-19 vaccination and a booster have the strongest immune protection from the disease. Boosting after previous infection increases antibody levels in both mothers and newborns, providing maximum possible protection to infants as SARS-CoV-2 evolves.
Recent studies have found no link between COVID-19 vaccination and sudden cardiac arrest in athletes. However, a small decrease in VO2 Max has been observed after vaccination, which may be temporary and have minimal clinical relevance.
A new Northwestern Medicine study measures resilience in biomedical scientists during COVID-19, revealing that resiliency did not guarantee career advancement. The study found that women scientists faced greater household responsibilities and social pressure to advance their careers, leading to significant career setbacks.
A large study found that fully vaccinated individuals have lower concentrations of inflammatory markers than unvaccinated participants after symptomatic COVID-19 infection. This suggests that vaccination significantly reduces morbidity and mortality by reducing elevated levels of cytokines and chemokines.
A new adjuvanted intranasal vaccine has shown promise in protecting both young and old mice against SARS-CoV-2 infection. The vaccine combines an RNA-based molecule with a nanoemulsion, resulting in a strong immune response.
A large head-to-head comparison study of the Moderna and Pfizer-BioNTech vaccines found that the Moderna vaccine was associated with a slightly lower risk of adverse events for older adults. The study also showed that the Moderna vaccine was linked to a 4% lower risk of pulmonary embolism and a 15% lower risk of diagnosed COVID-19.
A study of 6.3 million US older adults found the Moderna mRNA-1273 vaccine associated with a slightly lower risk of several adverse events, possibly due to improved protection against COVID-19. Future research should consider frailty in assessing vaccine performance and formally disentangle differences in safety and effectiveness.
A study from the University of Gothenburg found that even vulnerable people with compromised immune systems achieved good antibody levels after three doses of COVID-19 mRNA vaccine. This is particularly significant for those at risk of severe Covid-19, as they showed catch-up antibody responses and high levels of hybrid immunity.
A study using wastewater metrics found accurate assessments of county SARS-CoV-2 incidence and may be the best metric for monitoring virus circulation. Home testing increases and vaccination treatment decrease disease acuity, making wastewater surveillance a reliable option.
Researchers developed a novel vaccine against SARS-CoV-2 by selecting antigen variants with low binding affinity, resulting in higher neutralizing antibody concentrations. This design strategy may also improve vaccine efficacy for other coronaviruses and herpes viruses.
Researchers leveraged genomics, transcriptomics, proteomics, and metabolomics to understand COVID-19 virus structure and mechanism of action. Multi-omics approaches identified potential antiviral drugs and characteristics of pathogens, informing vaccine design and therapeutic development.
A significant fall in Covid-related hospitalisations and mortality among UK cancer patients was found following the vaccine rollout. The study, published in Scientific Reports, revealed that age was a greater predictor of mortality rates than the type of cancer.
A study analyzing wearable device data from over 190,000 users found that vaccinated individuals experience less severe COVID-19 symptoms and recover faster. Vaccination reduces the risk of severe disease, hospitalization, ICU admission, and death.
Researchers developed a bioinformatic tool that selects parts of proteins to elicit strong immune responses. This approach, grounded in immunological theory, was four times more efficient than current methods, suggesting better vaccine protection against diseases.
Researchers at Western University have discovered a potential 'super molecule' called 5-OP-RU that can enhance the effectiveness of several vaccines for viral diseases. The molecule binds to a protein called MR1 before stimulating mucosa-associated invariant T (MAIT) cells, which are key players in fighting off infection.
A new study suggests that people's judgments of anti-vaxxers who die from COVID-19 are complex and influenced by political party affiliation and vaccination status. Researchers found that Democrats and vaccinated individuals were more likely to view anti-vaxxers as deserving worse outcomes, while Republicans and unvaccinated individual...
A study of 538,000 deaths in Florida and Ohio between March 2020 and December 2021 found significant excess mortality among Republican voters compared to Democratic voters. The disparity suggests differences in vaccination attitudes and uptake may have influenced pandemic severity and trajectory.
A large study found that vaccination can prevent COVID-19 hospitalizations with 205 individuals needed to be vaccinated, while preventing ED visits requires fewer vaccinations. The study's findings provide valuable insights into the vaccine's effectiveness, especially in older populations.
A team of medical leaders recommends a sustainably funded public-private partnership to combat misinformation, citing challenges faced by the TIOS-VY organization. The American College of Physicians calls for modernizing public health infrastructure, including increased funding and addressing disinformation, especially on social media.
A new study found that COVID-19 vaccines significantly reduced dementia-related deaths in long-term care and nursing homes, with a 77% decrease in the second year. However, deaths among those living at home did not decline as much, with only a 16% reduction.
Scientists have teamed up to improve drug delivery by designing more effective lipid nanoparticles. Their latest study documents how high-throughput workflows can produce and characterize LNPs at record speed, with neatly ordered structures leading to better silencing of faulty genes in human neurons.
A new study found that rural areas experienced higher excess deaths during the second year of the pandemic, despite vaccines being widely available in urban areas. The study highlights the role of healthcare inequities, vaccine skepticism, and partisanship in exacerbating mortality rates in rural communities.
A survey of 2,000 German adults found that people with higher levels of empathy and cosmopolitanism are more likely to prioritize sharing vaccine supplies internationally. The study suggests that there is substantial public support for international vaccine solidarity when infection rates are at a modest level and falling.
Studies showed mRNA vaccines provided long-term immunity against severe COVID-19 outcomes in cancer patients. The study found waning immunity after up to 4 mRNA vaccine doses, highlighting the need for booster shots.
A new Boston University study found that COVID vaccines likely do not affect menstrual cycle regularity, bleed length, or pain. Menstrual cycles increased by 1.1 days after a first dose and 1.3 days after a second, but these changes resolved within one to two cycles.
Researchers at University of Bristol found that Long Covid is not caused by an immune inflammatory reaction to COVID-19. Instead, persistent immune activation and inflammation may persist for months after COVID-19, correlating with severe disease. The study suggests a new direction for understanding and potentially treating this debili...
Research by the University of Southampton found that repeated COVID-19 vaccine doses increase immune response in blood cancer patients, generating higher-quality antibodies. Booster vaccinations are essential for maintaining protection against COVID-19 in immunocompromised individuals.
A new analysis found that COVID-19 vaccination significantly reduced income-related disparities in disease incidence between low- and high-income communities in Los Angeles. Vaccination efforts in underserved communities were crucial in reducing these disparities.
A prospective study of COVID-19 mRNA vaccines found progressively declining immune functions in individuals with chronic lymphocytic leukemia (CLL). The study, published in PLOS Medicine, showed that CLL patients experienced reduced antibody responses to the vaccines.
Researchers developed a biodegradable nanoparticle that reaches dendritic cells in mice with melanoma and colon cancer, activating an immune response. The nanoparticle improves survival rates for these cancers, with half of mice surviving long-term after treatment.
Scientists at the University of Cambridge identified a signature in the blood that could predict how well an individual responds to vaccines. They found that those with higher levels of age-associated B cells are less effective after vaccination.